L. Bjermer (Lund, Sweden), R. Dal Negro (Verona, Italy)
A human lung reperfusion model for monitoring the initial pulmonary absorption of drugs from aerosol devices
M. Freiwald, A. Valotis, A. Kirschbaum, M. McClellan, T. Mürdter, P. Fritz, G. Friedel, P. Högger (Würzburg, Gerlingen, Stuttgart, Germany)
|  |
The generation of monodisperse pharmacological aerosols using a spinning-top aerosol generator (STAG)
M. F. Biddiscombe, P. J. Barnes, O. S. Usmani (London, United Kingdom)
| |
Aerosol particle size output from a new nebuliser system, measured by cascade impaction
J. P. Young, E. R. Ibanez, T. J. Hurren (Bognor Regis, United Kingdom)
| |
Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator therapeutic response as that administered by the Rotahaler in adults with chronic obstructive pulmonary disease
B. Brashier, B. Trupti, P. Mahadik, P. Gokhale, J. G. Gogtay, S. Salvi (Pune, Mumbai, India)
| |
Tiotropium dose emission is influenced by the inhalation flow and the recommended two inhalations for each dose
S. A. Al-Fadhl, K. H. Assi, B. J. Clark, H. Chrystyn (Bradford, United Kingdom)
| |
Inhaled long-acting β2-agonist: aerosol particle size and bronchodilator response
O. S. Usmani, M. F. Biddiscombe, P. J. Barnes (London, United Kingdom)
| |
Comparison of the release characteristics of formoterol dihydrate powder for inhalation delivered through two different types of multidose dry powder inhalers (MDPI)
B. Bidlingmaier, S. Mueller, B. Fyrnys (Bad Homburg, Germany)
| |
Influence of pulmonary function on spacer use for HFA-salbutamol inhalation in asthmatic patients
M. Fujimura, J. Hara, N. Ohkura, S. Myou (Kanazawa, Japan)
| |
Efficacy of solution beclomethasone- dipropionate-HFA in COPD and Br. Asthma
G. N. Tatsis, G. D. Tsoukalas, S. N. Boulia, Z. G. Agianiotaki, A. A. Ifanti, K. A. Kotsifas (Athens, Greece)
| |
Performance of salmeterol/fluticasone propionate HFA MDIs with and without counter are comparable
J. J. West, O. O‘Brien, J. C. Ellis, C. A. O‘Brien (Ware, United Kingdom)
| |
Patient satisfaction with fluticasone propionate/salmeterol (FSC) HFA with an integrated dose counter
W. R. Lincourt, C. Crim, K. K. Sheth, N. W. Locantore, J. R. Carranza Rosenzweig (Research Triangle Park, Lafayette, United States Of America)
| |
Real world handling performance of fluticasone propionate/salmeterol HFA MDI with an integrated dose counter in subjects with asthma or COPD
C. Crim, W. R. Lincourt, K. K. Sheth, N. W. Locantore (Research Triangle Park, Lafayette, United States Of America)
| |
Clinical observations on inhaled drug adherence
G. G. Barbulescu, L. I. Badulescu (Bucharest, Romania)
| |
A randomized trial of the effectiveness of nebulized therapy with epinephrine compared with salbutamol in the treatment of acute viral bronchiolitis
P. O. Simsek, A. T. Aslan, N. Kiper, E. Yalcin, D. Dogru, U. Ozcelik, S. Ercis, G. Hascelik, B. Ulus, S. Inan (Ankara, Turkey)
| |